151 related articles for article (PubMed ID: 22903312)
41. The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up.
Bouvier AM; Latournerie M; Jooste V; Lepage C; Cottet V; Faivre J
Eur J Cancer; 2008 Mar; 44(4):522-7. PubMed ID: 18255278
[TBL] [Abstract][Full Text] [Related]
42. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
43. Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period.
Chen CY; Lai CH; Lee KD; Huang SH; Dai YM; Chen MC
Gynecol Oncol; 2012 Dec; 127(3):625-30. PubMed ID: 22975362
[TBL] [Abstract][Full Text] [Related]
44. Second primary cancers in patients with lung carcinoma.
Levi F; Randimbison L; Te VC; La Vecchia C
Cancer; 1999 Jul; 86(1):186-90. PubMed ID: 10391579
[TBL] [Abstract][Full Text] [Related]
45. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
McCredie M; Macfarlane GJ; Bell J; Coates M
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
[TBL] [Abstract][Full Text] [Related]
46. Risk of second primary malignancies in women with papillary thyroid cancer.
Canchola AJ; Horn-Ross PL; Purdie DM
Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
[TBL] [Abstract][Full Text] [Related]
47. Second primary cancers in breast cancer patients in Slovenia.
Volk N; Pompe-Kirn V
Cancer Causes Control; 1997 Sep; 8(5):764-70. PubMed ID: 9328199
[TBL] [Abstract][Full Text] [Related]
48. Multiple primary cancers among colorectal cancer survivors in Queensland, Australia, 1996-2007.
Dasgupta P; Youlden DR; Baade PD
Cancer Causes Control; 2012 Aug; 23(8):1387-98. PubMed ID: 22729930
[TBL] [Abstract][Full Text] [Related]
49. Melanoma and additional primary cancers.
Retsas S; Mohith A; Bell J; Horwood N; Alexander H
Melanoma Res; 2000 Apr; 10(2):145-52. PubMed ID: 10803715
[TBL] [Abstract][Full Text] [Related]
50. Temporal trend in relative risk of second primary colorectal cancer.
Das A; Chak A; Cooper GS
Am J Gastroenterol; 2006 Jun; 101(6):1342-7. PubMed ID: 16771959
[TBL] [Abstract][Full Text] [Related]
51. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
[TBL] [Abstract][Full Text] [Related]
52. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
53. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001.
Soerjomataram I; Louwman WJ; de Vries E; Lemmens VE; Klokman WJ; Coebergh JW
Breast Cancer Res Treat; 2005 Sep; 93(1):91-5. PubMed ID: 16184464
[TBL] [Abstract][Full Text] [Related]
54. Risk of second breast cancer according to estrogen receptor status and family history.
Bouchardy C; Benhamou S; Fioretta G; Verkooijen HM; Chappuis PO; Neyroud-Caspar I; Castiglione M; Vinh-Hung V; Vlastos G; Rapiti E
Breast Cancer Res Treat; 2011 May; 127(1):233-41. PubMed ID: 20878464
[TBL] [Abstract][Full Text] [Related]
55. Associations between ocular melanoma and other primary cancers: an international population-based study.
Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
[TBL] [Abstract][Full Text] [Related]
56. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
57. Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours.
Clift AK; Drymousis P; Al-Nahhas A; Wasan H; Martin J; Holm S; Frilling A
Neuroendocrinology; 2015; 102(1-2):26-32. PubMed ID: 25824138
[TBL] [Abstract][Full Text] [Related]
58. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
[TBL] [Abstract][Full Text] [Related]
59. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden.
Hemminki K; Li X
Int J Cancer; 2003 Feb; 103(4):525-30. PubMed ID: 12478670
[TBL] [Abstract][Full Text] [Related]
60. Risk of colorectal cancer in patients with acute myocardial infarction and stroke: a nationwide cohort study.
Erichsen R; Sværke C; Sørensen HT; Sandler RS; Baron JA
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1994-9. PubMed ID: 24049127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
